Enjoy complimentary customisation on priority with our Enterprise License!
The nicotine gum market size is forecast to increase by USD 1.35 billion, at a CAGR of 5.71% between 2023 and 2028. The market's growth is influenced by several factors, including the rising number of individuals attempting to quit smoking, heightened awareness about the harmful effects of cigarette smoking, and the increasing prevalence of chronic diseases caused by smoking. As more people become conscious of the health risks associated with smoking, the demand for alternatives such as nicotine patches and cessation aids grows. Additionally, public health campaigns and regulations aimed at reducing smoking rates are further driving market expansion. These factors collectively contribute to the market's development, highlighting the ongoing efforts to combat smoking-related health issues and focus on smoking cessation and nicotine de-addiction. The market in North America is growing significantly as many people are trying to quit smoking in this region. In addition, the US, Mexico, and Canada are the major countries in North America that have huge potential for nicotine gums. Alchem International Pvt. Ltd., a key company, offers nicotine gums under the brand NicSelect.
The market shows an Accelerated CAGR during the forecast period.
To get additional information about the market report, Request Nicotine Gum Market Analysis Report Free Sample
The growing preference for the offline segment will increase the market growth. The Market encompasses the sales of nicotine replacement therapy (NRT) products, specifically e-cigarettes and chewing gums, in the context of tobacco consumption reduction. These gums are essential components of nicotine cessation programs, addressing health risks associated with lung cancer, cardiac diseases, and respiratory disorders. Pharmacies and supermarkets/hypermarkets dominate the distribution landscape, offering a wide range of NRT products, including nicotine gum brands like Nicorette. Consumers can easily access these gums, which provide long-lasting relief for nicotine cravings. Healthcare professionals often recommend NRTs to help individuals quit smoking, and new flavors and convenient delivery systems further enhance their appeal. Hence, such factors are fuelling the growth of this segment which in turn drives the market growth during the forecast period.
The 2-mg nicotine segment is estimated to witness significant growth during the forecast period. The market witnessed significant growth in 2022, with light smokers and health-conscious consumers being the primary consumers. Online stores have become a popular platform for purchasing nicotine gums and tobacco alternative gums, especially for those following smoking cessation programs. Government initiatives to reduce smoking rates and increase awareness about heart disease have boosted market demand.
The 2-mg nicotine segment was the largest segment and valued at USD 2.53 billion in 2018.
For a detailed summary of the market segments Request for Sample Nicotine Gum Market Analysis Report
Regulatory compliance and changing consumer preferences have led to the introduction of new products, such as flavored gums, lozenges, dissolvable films, tiny nicotine pouches, and personalized gum offerings. Smoking cessation awareness and the focus on health and wellbeing continue to drive market expansion during the forecast period. Hence, such factors are fuelling the growth of this segment, which in turn drives the market growth during the forecast period.
APAC is estimated to contribute 31% to the growth of the global market during the forecast period
Get a glance at the Nicotine Gum Market share of various regions View PDF Sample
Technavio's analysts have provided extensive insight into the market forecasting, detailing the regional trends and drivers influencing the market's trajectory throughout the forecast period. The Market in North America is experiencing significant growth due to increasing smoking cessation efforts. Online stores are becoming popular channels for purchasing nicorette gums as more light smokers and health-conscious consumers seek alternatives to traditional cigarettes. Government initiatives to reduce smoking rates and raise awareness about heart disease risks are driving demand. Regulatory compliance is a key consideration for market players, as nicorette gums must meet specific standards. Changing consumer preferences toward personalized health and wellbeing solutions are also fueling growth. Nicorette Gums, lozenges, dissolvable films, flavored gums, tiny nicotine pouches are some of the popular forms of nicotine replacement therapies. Smoking cessation awareness campaigns and the desire to improve overall health are major factors contributing to the market's expansion. Hence, such factors are driving the market growth during the forecast period.
The market is a significant segment of the nicotine products industry, catering to individuals seeking alternatives to tobacco consumption for nicotine cessation. Tobacco use, a leading cause of lung cancer, cardiac diseases, and respiratory disorders, has resulted in increased demand for harm reduction products like nicorette Gum. Brands like Nicorette offer long-lasting gums as smoking cessation aids, helping users manage nicotine cravings. Pharmacies and healthcare professionals recommend Nicorette Gum as part of comprehensive health awareness programs against the harmful effects of tobacco smoke. Harmful chemicals in tobacco contribute to heart conditions and respiratory problems. Nicotine replacement products, including nicorette Gum and patches, have gained popularity as smoking cessation aids. Supermarkets and health organizations stock these products, making them easily accessible to consumers. The market is expected to grow as more individuals become aware of the health risks associated with tobacco use and seek alternatives. Cigarette promotion and tobacco use remain prevalent issues, making the need for effective nicotine cessation aids more crucial than ever.
Increasing number of people trying to quit smoking drives the market growth. The global market continues to expand due to the rising number of individuals seeking to quit tobacco consumption. Nicotine products, including nicorette Gum, are popular nicotine cessation aids. The health risks of smoking, such as lung cancer, cardiac diseases, and respiratory disorders, are well-documented. As a result, healthcare professionals recommend nicotine replacement therapy (NRT) to help manage nicotine cravings. Nicorette, a well-known nicotine gum brand, offers long-lasting gums in various convenient delivery systems and new flavors.
Moreover, pharmacies, supermarkets, and hypermarkets stock a range of NRT products, including nicotine gums, tablets, chewing gums, and powders. Smoking cessation programs, such as those offered by health organizations and rehab centers, also promote the use as effective tools for quitting smoking. Hence, such factors are driving the market growth during the forecast period.
Growing new product launches related to nicotine is a primary trend in the market. The market witnesses continuous growth due to the introduction of new products, catering to the increasing demand for nicotine replacement therapy (NRT) and smoking cessation aids. Tobacco consumption, a leading cause of lung cancer, cardiac diseases, and respiratory disorders, has driven the need for alternative nicotine products. Nicorette, a popular nicotine gum brand, and Perrigo's upcoming 2 mg and 4 mg gums in regular, orange, and mint flavors, are set to enter the US market.
Moreover, these long-lasting gums offer convenient delivery systems to help manage nicotine cravings. Healthcare professionals recommend NRTs as part of smoking cessation programs. The 2mg and 4mg segments dominate the market, with pharmacies, tablets, chewing gums, and powders being the primary distribution channels. Hence, such factors are driving the market growth during the forecast period.
Health issues associated with smoking cessation products is a major challenge hindering the market growth. The market, a type of nicotine replacement therapy (NRT), may experience hindrances due to growing health concerns. Long-term use of it can lead to various health issues, including hair loss, skin irritation, elevated blood pressure, irregular heartbeat, insulin resistance, gastrointestinal problems, and nausea. Additionally, users of nicotine gums face dental problems due to continuous chewing.
Moreover, despite these health risks, nicorette Gum remain popular as smoking cessation aids. Tobacco consumption continues to pose significant health risks, such as lung cancer, cardiac diseases, and respiratory disorders. Nicorette Gums, offer a convenient delivery system for those seeking to quit smoking. Healthcare professionals often recommend it as part of smoking cessation programs. Hence, such factors are hindering the market growth during the forecast period.
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market forecasting growth and analysis.
The market growth and forecasting report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:
Alkalon AS, Cambrex Corp., Dr Reddys Laboratories Ltd., Enorama Pharma AB, Fertin Pharma AS, GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd., ITC Ltd., Johnson and Johnson Services Inc., Leeford Healthcare Ltd., Lil Drug Store Products Inc., Lucy Goods Inc., Major Pharmaceuticals Inc., Perrigo Co. Plc, Rogue Holdings LLC, Trumac Healthcare, and Walgreens Boots Alliance Inc.
The market analysis and report of qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The market research report provides comprehensive data (region wise segment analysis), with forecasts and estimates in "USD Billion" for the period 2024-2028, as well as historical data from 2018 - 2022 for the following segments.
The Market is a significant segment of the tobacco industry, featuring products that provide nicotine delivery through the chewing of gum. These gums are considered an alternative to traditional smoking, making them a popular choice among consumers looking to quit or reduce their tobacco intake. The market is driven by factors such as increasing health consciousness, growing awareness about the harmful effects of smoking, and the availability of over-the-counter nicotine replacement therapies. The market landscape depends on nicotine patches, nicotine patch, health conscious consumers, flavoured gums, personalization. The market is competitive, with major players like Pfizer, Novartis, and GlaxoSmithKline dominating the landscape. These companies invest heavily in research and development to produce innovative and effective nicotine gum products.
The market also sees continuous growth due to the entry of new players and the expansion of product offerings. The market is expected to grow in the coming years, with a focus on developing new flavors, improving product efficacy, and exploring new distribution channels. The market landscape depends on Pharmacy, long lasting gums, stress and anxiety levels, 2mg segment, 4mg segment. Additionally, the market is witnessing a shift towards online sales, as consumers increasingly prefer the convenience and privacy of purchasing nicotine gum online. In conclusion, the Market is a dynamic and growing industry, driven by consumer demand for alternative nicotine delivery methods and the ongoing efforts of companies to innovate and improve their offerings.
Market Scope |
|
Report Coverage |
Details |
Base year |
2023 |
Historic period |
2018-2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 5.71% |
Market growth 2024-2028 |
USD 1.35 billion |
Market structure |
Fragmented |
YoY growth 2023-2024(%) |
5.07 |
Regional analysis |
North America, Europe, APAC, South America, and Middle East and Africa |
Performing market contribution |
APAC at 31% |
Key countries |
US, Germany, France, China, and UK |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks, Nicotine Gum Market Industry Risks. |
Key companies profiled |
Alchem International Pvt. Ltd., Alkalon AS, British American Tobacco Plc, Cambrex Corp., Cipla Inc., Dr Reddys Laboratories Ltd., Enorama Pharma AB, Fertin Pharma AS, GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd., ITC Ltd., Johnson and Johnson Services Inc., Leeford Healthcare Ltd., Lil Drug Store Products Inc., Lucy Goods Inc., Major Pharmaceuticals Inc., Perrigo Co. Plc, Rogue Holdings LLC, Trumac Healthcare, and Walgreens Boots Alliance Inc. |
Market dynamics |
Parent market analysis, market growth analysis, Nicotine Gum market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Nicotine Gum market worth and condition analysis for forecast period, Nicotine Gum Market Growth Analysis. |
Customization purview |
If our Nicotine Gum Market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
BUY NOW Full Nicotine Gum Market Forecast Report and Discover more
We can help! Our analysts can customize this nicotine gum market growth analysis report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by Distribution Channel
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.